Washington, D.C. – May 21, 2007 -- A new study demonstrated that the active ingredient in AMITIZA® (lubiprostone), given 8 mcg twice a day, may improve symptom relief rates in adults with ...

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc., announced today that AMITIZA (lubiprostone), 24-mcg soft-gel capsules, approved by the US Food and Drug Administration ...

Lubiprostone is a member of a new class of bicyclic fatty acid derivatives known as prostones. Lubiprostone acts on type-2 chloride channels located on the apical side of gastrointestinal ...

Sucampo Pharmaceuticals Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD) First Patient Enrolled in Pivotal Studies BETHESDA, Md., Sept. 13 -- ...

Lubiprostone was significantly more effective in improving abdominal pain or bloating than placebo, according to results from a post-hoc analysis published in Alimentary Pharmacology and Therapeutics.

Moeser et al. Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine.

The first authorized generic version of Amitiza (lubiprostone; Mallinckrodt) has been made available by Par Pharmaceutical, Inc.. Lubiprostone, a chloride channel activator, is indicated for the ...

In February 2009, Sucampo entered into a license, commercialization, and supply agreement for lubiprostone with Abbott Japan Co. Ltd. under which Abbott received exclusive rights to commercialize ...

VIENNA — Lubiprostone was tolerable and improved hepatic markers among patients with nonalcoholic fatty liver disease, according to data presented at the International Liver Congress 2019.&ldquo ...

The FDA has expanded the indication for oral lubiprostone (Amitiza) to include opioid-induced constipation in chronic, non-cancer pain patients, according to a statement from the drug’s ...

Amitiza (Lubiprostone) Cost and Financial Assistance. Medically reviewed by Olivia Taylor, PharmD, BCPS — Written by Lindsay Ross-Hazel on March 24, 2025. Cost; Coupons and savings; ...

In February 2009, Sucampo entered into a license, commercialization, and supply agreement for lubiprostone with Abbott Japan Co. Ltd. under which Abbott received exclusive rights to commercialize ...